Karyopharm Receives Conditional MA in the UK for NEXPOVIO® (selinexor) for the Treatment of Multiple Myeloma
UK's MHRA granted conditional marketing authorization for NEXPOVIO® (selinexor) of Karyopharm Therapeutics
Read moreUK's MHRA granted conditional marketing authorization for NEXPOVIO® (selinexor) of Karyopharm Therapeutics
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.